Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil OKs GMO trials

The Brazilian authorities have approved four applications for trials of genetically modified crops. The national biosafety technical committee, the CTNBio, approved applications for: two trials of Monsanto’s insect-resistant and glyphosate-tolerant MON15985xMON88913 cotton; one of Monsanto’s glyphosate-tolerant MON89788 soybeans and its glyphosate-tolerant and insect-resistant MON87701xMON89788 soybeans; and Syngenta’s insect-resistant and herbicide-tolerant maize at its April meeting. It further authorised nine biosafety quality certificates. A proposal to amend regulations governing the commercial release of GMOs remains under review. It was submitted by the commission’s new president, Edilson Paiva, at the February meeting. The application for commercial release of Bayer CropScience’s glufosinate-tolerant LibertyLink rice has headed the agenda for many months. The commission withdrew it from the April agenda for continuing lack of documentation. There is no approved GM rice product in Brazil.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG002997

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel